They showed that CYP activity and antipyrine metabolism decreased only in severe disease compared to inactive cirrhosis, mild-moderate liver disease or healthy volunteers (Farrell et al., 1979; Bauer et al., 1994; Grieco et al., 1998). The gene discussed is PPIG; the disease is liver disorder.